We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

A bitter pill

7 April 2005

The retailer has sugared the pill by promising to sell its subscale healthcare business and return most of the proceeds to shareholders. But this can’t conceal the bitter taste underneath. Profits are still falling at the core chemists chain.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)